The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: Lenvamel, a multicenter retrospective study of the French Group of Skin Cancers.
 
Perrine Rousset
No Relationships to Disclose
 
Charlée Nardin
Honoraria - Bristol Myers Squibb Foundation; MSD; Novartis
Consulting or Advisory Role - Bristol Myers Squibb Foundation; MSD; Novartis
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation; MSD; Novartis
 
Eve Maubec
No Relationships to Disclose
 
Valentine Heidelberger
No Relationships to Disclose
 
Alexandra Picard
No Relationships to Disclose
 
Emilie Gérard
No Relationships to Disclose
 
Nora Kramkimel
No Relationships to Disclose
 
Maud Steff
No Relationships to Disclose
 
Gaëlle Quéreux
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; MSD Oncology; MSD Oncology; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Pierre Fabre
 
Caroline Gaudy-Marqueste
Honoraria - BMS france; Pierre Fabre
Consulting or Advisory Role - Pierre Fabre
Research Funding - BMS, Pfizer, Amgen, GSK, Roche, Novartis, Pierre Fabre, Replimune, MSD, Janssen, Kartos, IFX, Huyabio, Regeneron, IO Biotech, Philogen, Sotio, Kinnate, Astra Zenecca, Cytovation (Inst)
Travel, Accommodations, Expenses - BMS France; MSD Oncology; Pierre Fabre
 
Candice Lesage
Consulting or Advisory Role - Bristol Myers Squibb Foundation; MSD; NOVARTIS; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; NOVARTIS; Pfizer
 
Claire Mignard
No Relationships to Disclose
 
Geraldine Jeudy
No Relationships to Disclose
 
Thomas Jouary
No Relationships to Disclose
 
Mélanie Saint-Jean
Honoraria - Bristol Myers Squibb Foundation; MSD; Novartis
Travel, Accommodations, Expenses - NOVARTIS; Pierre Fabre
 
Barouyr Baroudjian
Honoraria - BMS; MSD; Novartis; Pierre Fabre; Pierre Fabre; Sanofi
Consulting or Advisory Role - BMS; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - BMS; MSD; Pierre Fabre
 
Elodie Archier
No Relationships to Disclose
 
Laurent Mortier
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis; Sun Pharma
Consulting or Advisory Role - BMS GmbH & Co. KG; Novartis; Sun Pharma
Research Funding - MSD Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche/Genentech
 
Celeste Lebbe
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Inflax; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Other Relationship - Avantis Medical Systems; BMS; InflaRx; Jazz Pharmaceuticals; MSD; Novartis; Pierre Fabre; Sanofi
 
Henri Montaudie
Consulting or Advisory Role - BMS; MSD Oncology; Pierre Fabre
Research Funding - BMS (Inst); LEO Pharma (Inst)
Travel, Accommodations, Expenses - BMS; MSD Oncology; MSD Oncology; Pierre Fabre